Ozempic Alternatives: Affordable Weight Loss Medications in 2026

Ozempic is expensive and hard to find. Here are the best alternatives for weight loss in 2026, including Wegovy, Mounjaro, Zepbound, and compounded semaglutide.

Majesta Health Medical TeamMedically Reviewed
Reviewed May 1, 20267 min read

If you've tried to get Ozempic recently, you know the struggle. Between shortages, insurance hurdles, and a price tag of nearly $1,000 per month, getting this medication has become increasingly difficult.

The good news? There are effective alternatives, some of which are more affordable and more accessible than Ozempic itself. Here's a complete guide to your options in 2026.

First, What Is Ozempic?

Ozempic is a brand-name medication containing semaglutide, FDA-approved for type 2 diabetes but widely prescribed off-label for weight loss. Its popularity has led to nationwide shortages and skyrocketing prices.

Your Ozempic Alternatives

### 1. Wegovy Wegovy contains the same active ingredient as Ozempic (semaglutide) at a higher dose specifically approved for weight loss.

  • Cost: $1,349/month without insurance
  • How it's taken: Once-weekly injection
  • Effectiveness: 15% average weight loss in clinical trials (STEP 1)
  • Best for: People whose insurance covers weight loss medications
  • ### 2. Zepbound (Tirzepatide) Zepbound targets both GLP-1 and GIP receptors, a dual mechanism that may produce even greater weight loss.

  • Cost: $1,060/month without insurance
  • How it's taken: Once-weekly injection
  • Effectiveness: Up to 20.9% average weight loss in SURMOUNT trials
  • Best for: People looking for the newest, most potent option (if cost isn't a barrier)
  • ### 3. Mounjaro (Tirzepatide) Same medication as Zepbound but FDA-approved for type 2 diabetes. Sometimes prescribed off-label for weight loss.

  • Cost: $1,069/month without insurance
  • Note: Faces periodic shortages, like Ozempic
  • ### 4. Compounded Semaglutide Contains the exact same active ingredient as Ozempic and Wegovy, prepared by FDA-registered compounding pharmacies.

  • Cost: $179-$299/month, roughly 80% less than brand names
  • How it's taken: Once-weekly injection
  • Effectiveness: Same as brand-name semaglutide
  • Best for: Most people paying out of pocket
  • Available at: Majesta Health starting at $179/month
  • ### 5. Compounded Tirzepatide Offers the dual GLP-1/GIP agonist at a reduced cost.

  • Cost: Typically $350-$500/month
  • Best for: People who want the dual-mechanism medication but can't afford Zepbound
  • ### 6. Over-the-Counter Supplements (Not a Replacement) You'll see many OTC supplements claiming to be "natural Ozempic alternatives." Be cautious, these are not FDA-approved for weight loss and no supplement can replicate the effects of prescription GLP-1 medications.

    Comparison at a Glance

    OptionMonthly CostEffectivenessAvailability
    Ozempic$93515% avg weight lossLimited (shortages)
    Wegovy$1,34915% avg weight lossModerate
    Zepbound$1,060Up to 20.9% avg weight lossImproving
    Compounded semaglutide$179-$299Same as Ozempic/WegovyGood
    Compounded tirzepatide$350-$500Same as Zepbound/MounjaroGood

    Which Alternative Is Right for You?

    If your insurance covers weight loss medications: Wegovy or Zepbound may be your best option.

    If you're paying out of pocket: Compounded semaglutide offers the best value, the same active ingredient at roughly 80% less cost. At Majesta Health, it starts at just $179 for the first month.

    If you want the latest dual-agonist technology: Consider compounded tirzepatide or Zepbound, depending on your budget.

    The Bottom Line

    Ozempic isn't the only option, and for many people, it may not be the best one.

    Ready to explore your options? Start your 2-minute medical assessment to connect with a board-certified physician.


    This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider. Individual results may vary. Clinical data referenced from STEP and SURMOUNT trials published in The New England Journal of Medicine.

    <!-- related-2026-injected -->

    Related 2026 guides

  • Cheapest semaglutide online in 2026
  • Compounded semaglutide cost in 2026
  • Compounded vs brand-name GLP-1 medications: the honest 2026 guide
  • Compounded tirzepatide online in 2026
  • Frequently Asked Questions

    What is a cheaper alternative to Ozempic?

    The cheapest legal alternatives in 2026 are compounded semaglutide and compounded tirzepatide through US-licensed telehealth providers, typically $179 to $399 a month all-in (physician, medication, shipping). For brand-name options, Zepbound vials through LillyDirect (around $349 to $499 a month) are the cheapest manufacturer-direct path. GoodRx coupons on Ozempic, Wegovy, and Mounjaro reduce retail price by 10 to 25 percent but still leave the monthly cost above $900.

    What is the closest alternative to Ozempic for weight loss?

    Wegovy is the closest clinically and structurally because it is the same molecule (semaglutide) by the same manufacturer (Novo Nordisk) with FDA approval specifically for weight management at a higher dose ceiling. Compounded semaglutide is the closest functionally because it uses the same active pharmaceutical ingredient and can be dosed in the weight-management range under physician supervision. Mounjaro and Zepbound (tirzepatide, Eli Lilly) are mechanistically different (dual GIP and GLP-1 receptor agonist) and produced greater average weight reduction in head-to-head trials.

    Is there a generic version of Ozempic?

    No generic version of Ozempic exists in the United States. Semaglutide is on patent in the US until 2031. Compounded semaglutide is not a generic. It is a customized prescription formulation prepared by a state-licensed compounding pharmacy under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered.

    Can I switch from Ozempic to a cheaper alternative?

    Yes, with physician approval. Switching from Ozempic to compounded semaglutide is the most common transition for patients seeking lower cost on the same molecule. Switching to tirzepatide (Mounjaro, Zepbound, or compounded) requires a fresh clinical evaluation because the medication mechanism and titration schedule differ. A US-licensed physician reviews your dose history, side effects, and weight progress, then designs the transition. Do not switch GLP-1 medications without physician supervision.

    Is compounded semaglutide a safe Ozempic alternative?

    When prescribed by a US-licensed physician and dispensed by a state-licensed compounding pharmacy that holds NABP accreditation and LegitScript certification, compounded semaglutide operates within the same regulatory framework that allows individualized prescription preparation. Patients should verify: the physician is licensed in their state, the pharmacy has documented NABP and LegitScript credentials, and the platform is HIPAA-compliant. Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered.

    Medically reviewed

    Majesta Health Medical Team

    Clinical Editorial Team

    All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.

    Credentials and accreditation
    • US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
    • Board-certified in primary care and obesity medicine
    • Active state medical licensure required for every prescribing clinician
    • Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
    • Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
    • Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)
    Areas of expertise
    GLP-1 receptor agonist therapy (semaglutide, tirzepatide, liraglutide)Chronic weight managementObesity medicineCompounded medication clinical oversightTelehealth informed consent and patient screening
    Have a question for our medical team? See our full clinical team page or contact support.

    Ready to Reserve Your Spot?

    Join the founding-member waitlist for priority access and locked-in pricing.

    Start Your Assessment